Terns Pharmaceuticals Stock Market Value
| TERN Stock | USD 5.08 0.03 0.59% |
| Symbol | Terns |
Terns Pharmaceuticals Price To Book Ratio
Is Terns Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Terns Pharmaceuticals. If investors know Terns will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Terns Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.27) | Revenue Per Share 0.035 | Return On Assets (0.23) | Return On Equity (0.34) |
The market value of Terns Pharmaceuticals is measured differently than its book value, which is the value of Terns that is recorded on the company's balance sheet. Investors also form their own opinion of Terns Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Terns Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Terns Pharmaceuticals' market value can be influenced by many factors that don't directly affect Terns Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Terns Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Terns Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Terns Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Terns Pharmaceuticals 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Terns Pharmaceuticals' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Terns Pharmaceuticals.
| 04/02/2024 |
| 05/02/2024 |
If you would invest 0.00 in Terns Pharmaceuticals on April 2, 2024 and sell it all today you would earn a total of 0.00 from holding Terns Pharmaceuticals or generate 0.0% return on investment in Terns Pharmaceuticals over 30 days. Terns Pharmaceuticals is related to or competes with Invesco Trust, LSI Industries, American Funds, and Merck. Terns Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops small-molecule single-agent and combin... More
Terns Pharmaceuticals Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Terns Pharmaceuticals' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Terns Pharmaceuticals upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 5.39 | |||
| Information Ratio | 7.0E-4 | |||
| Maximum Drawdown | 27.76 | |||
| Value At Risk | (8.38) | |||
| Potential Upside | 8.64 |
Terns Pharmaceuticals Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Terns Pharmaceuticals' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Terns Pharmaceuticals' standard deviation. In reality, there are many statistical measures that can use Terns Pharmaceuticals historical prices to predict the future Terns Pharmaceuticals' volatility.| Risk Adjusted Performance | 0.0162 | |||
| Jensen Alpha | (0.11) | |||
| Total Risk Alpha | (0.37) | |||
| Sortino Ratio | 7.0E-4 | |||
| Treynor Ratio | 0.0165 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Terns Pharmaceuticals' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Terns Pharmaceuticals Backtested Returns
We consider Terns Pharmaceuticals moderately volatile. Terns Pharmaceuticals owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0291, which indicates the firm had a 0.0291% return per unit of risk over the last 3 months. We have found twenty-nine technical indicators for Terns Pharmaceuticals, which you can use to evaluate the volatility of the company. Please validate Terns Pharmaceuticals' Risk Adjusted Performance of 0.0162, semi deviation of 5.23, and Coefficient Of Variation of 8737.28 to confirm if the risk estimate we provide is consistent with the expected return of 0.16%. Terns Pharmaceuticals has a performance score of 2 on a scale of 0 to 100. The entity has a beta of 3.22, which indicates a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Terns Pharmaceuticals will likely underperform. Terns Pharmaceuticals right now has a risk of 5.52%. Please validate Terns Pharmaceuticals potential upside, as well as the relationship between the kurtosis and day typical price , to decide if Terns Pharmaceuticals will be following its existing price patterns.
Auto-correlation | -0.77 |
Almost perfect reverse predictability
Terns Pharmaceuticals has almost perfect reverse predictability. Overlapping area represents the amount of predictability between Terns Pharmaceuticals time series from 2nd of April 2024 to 17th of April 2024 and 17th of April 2024 to 2nd of May 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Terns Pharmaceuticals price movement. The serial correlation of -0.77 indicates that around 77.0% of current Terns Pharmaceuticals price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.77 | |
| Spearman Rank Test | -0.72 | |
| Residual Average | 0.0 | |
| Price Variance | 0.04 |
Terns Pharmaceuticals lagged returns against current returns
Autocorrelation, which is Terns Pharmaceuticals stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Terns Pharmaceuticals' stock expected returns. We can calculate the autocorrelation of Terns Pharmaceuticals returns to help us make a trade decision. For example, suppose you find that Terns Pharmaceuticals has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Terns Pharmaceuticals regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Terns Pharmaceuticals stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Terns Pharmaceuticals stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Terns Pharmaceuticals stock over time.
Current vs Lagged Prices |
| Timeline |
Terns Pharmaceuticals Lagged Returns
When evaluating Terns Pharmaceuticals' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Terns Pharmaceuticals stock have on its future price. Terns Pharmaceuticals autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Terns Pharmaceuticals autocorrelation shows the relationship between Terns Pharmaceuticals stock current value and its past values and can show if there is a momentum factor associated with investing in Terns Pharmaceuticals.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
When determining whether Terns Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Terns Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Terns Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Terns Pharmaceuticals Stock:Check out Terns Pharmaceuticals Correlation, Terns Pharmaceuticals Volatility and Terns Pharmaceuticals Alpha and Beta module to complement your research on Terns Pharmaceuticals. To learn how to invest in Terns Stock, please use our How to Invest in Terns Pharmaceuticals guide.You can also try the Competition Analyzer module to analyze and compare many basic indicators for a group of related or unrelated entities.
Complementary Tools for Terns Stock analysis
When running Terns Pharmaceuticals' price analysis, check to measure Terns Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Terns Pharmaceuticals is operating at the current time. Most of Terns Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Terns Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Terns Pharmaceuticals' price. Additionally, you may evaluate how the addition of Terns Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Transaction History View history of all your transactions and understand their impact on performance |
Terns Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.